Duopharma Biotech (7148.KU) - Malaysia
(2nd) quarter ended Jun 30:
Figures Are In Ringgit (MYR).
2026 2025
Revenue 234,356,000 221,782,000
PreTax Profit 39,300,000 26,584,000
Net Profit 29,869,000 20,204,000
Earnings Per Share 3.11 Sen 2.10 Sen
Dividend 1.50 Sen 1.50 Sen
6 months ended Jun 30:
Revenue 482,236,000 484,520,000
PreTax Profit 79,708,000 60,321,000
Net Profit 60,586,000 45,844,000
Earnings Per Share 6.30 Sen 4.77 Sen
Dividend 1.50 Sen 1.50 Sen
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。